Verity & Verity’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $477K | Sell |
3,965
-426
| -10% | -$49.2K | 0.04% | 101 |
|
|
2025
Q4 | $462K | Buy |
4,391
+449
| +11% | +$42.1K | 0.04% | 107 |
|
|
2025
Q3 | $331K | Sell |
3,942
-152
| -4% | -$12.5K | 0.03% | 114 |
|
|
2025
Q2 | $324K | Buy |
4,094
+376
| +10% | +$29.9K | 0.03% | 115 |
|
|
2025
Q1 | $334K | Sell |
3,718
-1,211
| -25% | -$113K | 0.03% | 107 |
|
|
2024
Q4 | $490K | Buy |
4,929
+270
| +6% | +$27.8K | 0.04% | 95 |
|
|
2024
Q3 | $529K | Buy |
4,659
+1,262
| +37% | +$150K | 0.05% | 82 |
|
|
2024
Q2 | $421K | Sell |
3,397
-180
| -5% | -$23.2K | 0.05% | 85 |
|
|
2024
Q1 | $472K | Sell |
3,577
-30
| -0.8% | -$3.7K | 0.05% | 79 |
|
|
2023
Q4 | $393K | Hold |
3,607
| – | – | 0.05% | 81 |
|
|
2023
Q3 | $371K | Hold |
3,607
| – | – | 0.05% | 78 |
|
|
2023
Q2 | $416K | Sell |
3,607
-2,638
| -42% | -$300K | 0.05% | 75 |
|
|
2023
Q1 | $664K | Sell |
6,245
-3,931
| -39% | -$424K | 0.08% | 79 |
|
|
2022
Q4 | $1.13M | Buy |
10,176
+7,836
| +335% | +$801K | 0.15% | 76 |
|
|
2022
Q3 | $202K | Hold |
2,340
| – | – | 0.03% | 99 |
|
|
2022
Q2 | $213K | Buy |
+2,340
| New | +$207K | 0.03% | 95 |
|
|
2021
Q4 | – | Sell |
-2,435
| Closed | -$216K | – | 103 |
|
|
2021
Q3 | $216K | Buy |
+2,435
| New | +$185K | 0.03% | 101 |
|
|
2021
Q1 | – | Sell |
-2,620
| Closed | -$213K | – | 102 |
|
|
2020
Q4 | $213K | Hold |
2,620
| – | – | 0.04% | 95 |
|
|
2020
Q3 | $203K | Buy |
+2,620
| New | +$205K | 0.04% | 82 |
|
|
2020
Q1 | – | Sell |
-4,795
| Closed | -$416K | – | 101 |
|
|
2019
Q4 | $416K | Hold |
4,795
| – | – | 0.08% | 91 |
|
|
2019
Q3 | $385K | Hold |
4,795
| – | – | 0.08% | 90 |
|
|
2019
Q2 | $384K | Hold |
4,795
| – | – | 0.08% | 85 |
|
|
2019
Q1 | $381K | Buy |
4,795
+1,190
| +33% | +$89K | 0.09% | 94 |
|
|
2018
Q4 | $263K | Buy |
3,605
+241
| +7% | +$17K | 0.07% | 98 |
|
|
2018
Q3 | $228K | Buy |
+3,364
| New | +$214K | 0.06% | 99 |
|
|
2018
Q2 | – | Sell |
-3,993
| Closed | -$208K | – | 101 |
|
|
2018
Q1 | $208K | Buy |
+3,993
| New | +$216K | 0.06% | 95 |
|
|
2017
Q4 | – | Sell |
-3,355
| Closed | -$205K | – | 96 |
|
|
2017
Q3 | $205K | Hold |
3,355
| – | – | 0.06% | 92 |
|
|
2017
Q2 | $205K | Buy |
+3,355
| New | +$204K | 0.06% | 87 |
|
Other funds holding MRK
VCM
VPM
Verity & Verity's MRK Position: Q1 2026 in Review
Verity & Verity reduced its Merck (MRK) stake by 9.7% in Q1 2026, selling an estimated $49.2K and leaving 3,965 shares worth $477K. The position accounts for 0.04% of the portfolio, ranked #101.
Verity & Verity first reported a position in MRK in Q2 2017 and has held it in 28 quarters since. The position peaked at $1.13M in Q4 2022. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Verity & Verity held 3,965 shares of Merck worth $477K as of Q1 2026.
- Verity & Verity sold 426 Merck shares in Q1 2026, an estimated $49.2K.
- Merck made up 0.04% of Verity & Verity's portfolio in Q1 2026, its #101 holding.
- Verity & Verity first reported a position in Merck in Q2 2017 and has held it in 28 quarters since.
- Verity & Verity's Merck position peaked at $1.13M in Q4 2022.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Verity & Verity's 13F filing for Q1 2026, filed 15 Apr 2026.